Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (HTS, Omics Technologies) - Global Forecast to 2025

  • ID: 4090365
  • Report
  • Region: Global
  • 150 Pages
  • Markets and Markets
1 of 6
Human Microbiome Market Worth 899.1 Million USD by 2025

FEATURED COMPANIES

  • Enterome Bioscience
  • Merck & Co., Inc.
  • Metabiomics Corporation
  • OSEL, Inc.
  • Second Genome, Inc.
  • Vedanta Biosciences, Inc.
  • MORE

The global human microbiome market is estimated to reach USD 899.1 million by 2025, growing at a CAGR of 21.1% during the forecast period (2022–2025).

Factors such as increased focus on human microbiome therapy, growing demand for human microbiomes as new validated targets for drug development, and the need for early disease detection and diagnosis are expected to drive the growth of the human microbiome market.

By product, the global human microbiome market is classified into probiotics, prebiotics, foods, medical foods, supplements, diagnostic devices, and drugs. The expectation that microbiome products, which will aid in the early-stage treatment of chronic diseases and various disorders, will be available in the market in the future is a key driver for the growth of this market. Other factors such as the rise in aging population, incidence of chronic health problems, and the need to cut healthcare costs will increase the adoption of microbiome-derived products. However, patent applications of microbiome-derived products will require clinical evidence and regulatory approvals; therefore, the promise of significant investment in this segment is uncertain.

Europe currently forms the largest human microbiome market in terms of demand for prebiotics and probiotics. The North American region is expected to register the highest growth rate due to its immense growth opportunities. Scientific evidence of health benefits of certain ingredients such as probiotics, prebiotics, etc. and the search for new opportunities to add value to the existing products are also expected to propel the global market growth. The demand for prebiotics and probiotics is increasing across various regions owing to the awareness among consumers regarding the favorable benefits of the microbiome community also referred as “friendly” bacteria. Most of the consumers prefer these products for maintaining good health and to use enhanced efficiency of ingredients, which offer products with bio-therapeutic properties. With the advancement in technology, the usage of probiotics is likely to extend beyond the current arena of gut, dental, and immune health to several other areas of human health.

Moreover, the rising incidence of cardiac diseases and other diseases such as diabetes and obesity are also expected to contribute to the growth of the human microbiome market. Increasing side effects and diminishing of human gut flora, due to excessive use of antibiotics, is likely to drive the growth of the human microbiome market. The application market is also expected to be a prominent segment owing to the use of microbiome as diagnostics and therapeutics.

The competitive landscape covers the current product pipelines of the industry players in various stages of the clinical trial development. The company profiles comprise the basic views on the key players in the human microbiome market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future.
The above mentioned market research data, market potential, future market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding market penetration, product development/innovation, market development, market diversification, and competitive assessment, product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful in the market.

Research Coverage:

The report provides a picture on human microbiome across different industry verticals and regions. It aims at estimating the market size and future growth potential of this market across different segments such as product, disease, application, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market by providing them the closest approximations of the revenue numbers for the overall human microbiome market and the subsegments. This report will help stakeholders to better understand the competitor landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. The report also helps the stakeholders to understand the pulse of the market and provides them information on key market drivers, restraints, challenges, and opportunities.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the human microbiome market. The report analyzes the human microbiome market by product, application, disease, and region
  • Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the human microbiome market
  • Market Development: Comprehensive information about the lucrative emerging markets, by product and region
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the human microbiome market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, and manufacturing capabilities of leading players in the human microbiome market
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Enterome Bioscience
  • Merck & Co., Inc.
  • Metabiomics Corporation
  • OSEL, Inc.
  • Second Genome, Inc.
  • Vedanta Biosciences, Inc.
  • MORE
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Approach
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.3.1 Key Data from Secondary Sources
2.3.2 Key Data from Primary Sources
2.3.3 Key Industry Insights
2.3.4 Assumptions

3 Executive Summary

4 Premium Insights
4.1 Human Microbiome: Market Overview
4.2 Global Human Microbiome Market, By Product (2022)
4.3 Human Microbiome Market: Geographic Growth Opportunities
4.4 Human Microbiome Market: Geographic Mix
4.5 Human Microbiome Market: Developing vs. Developed Regions
4.6 Human Microbiome Research Spending Market, By Technology

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increased Focus on Human Microbiome Therapy
5.2.1.2 Human Microbiome as New Validated Target for Drug Development
5.2.1.3 Human Microbiome for Early Disease Detection and Diagnosis
5.2.2 Restraints
5.2.2.1 Lack of Expertise and Detailed Research
5.2.2.2 Barriers in Proving the Causal Link Between Dysbiosis and Disease
5.2.3 Opportunities
5.2.3.1 Investigational New Drug (IND) Requirements for Fecal Microbiota
5.2.3.2 Increasing Collaborations Create Growth Opportunities
5.2.4 Challenge
5.2.4.1 Government Regulations
5.2.5 Burning Issues
5.2.5.1 Abundant Opportunities in the Human Microbiome Field and Tremendous Research Investments
5.2.5.2 Development of Human Microbiome Therapeutic Products
5.3 Human Microbiome Market: Patents
5.4 Human Microbiome Market: Funding

6 Human Microbiome Market, By Product
6.1 Introduction
6.2 Probiotics
6.3 Foods
6.4 Prebiotics
6.5 Medical Foods
6.6 Diagnostic Devices
6.7 Drugs
6.8 Other Probiotic Supplements

7 Human Microbiome Market, By Application
7.1 Introduction
7.2 Therapeutics
7.3 Diagnostics

8 Human Microbiome Market, By Disease
8.1 Introduction
8.2 Acute Diarrhea
8.3 Obesity
8.4 Diabetes
8.5 Autoimmune Disorders
8.6 Cancer
8.7 Mental Disorders
8.8 Other Diseases

9 Human Microbiome Research Spending Market, By Product
9.1 Introduction
9.2 Instruments
9.2.1 Laboratory Instruments
9.2.2 Analyzers
9.3 Consumables
9.3.1 Kits
9.3.2 Reagents

10 Human Microbiome Research Spending Market, By Technology
10.1 Introduction
10.2 Cell Culture Technology
10.3 High-Throughput Technology
10.4 Omics Technology
10.5 Computational Tools

11 Human Microbiome Market, By Region
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.4 Asia-Pacific
11.5 Rest of the World (RoW)

12 Competitive Landscape
12.1 Overview
12.2 Competitive Situation and Trends
12.2.1 Agreements, Partnerships, and Collaborations
12.2.2 Expansions
12.2.3 Product Launches and Approvals
12.2.4 Other Developments

13 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, Mnm View) -
13.1 Enterome Bioscience
13.2 E.I. du Pont de Nemours and Company
13.3 Merck & Co., Inc.
13.4 Metabiomics Corporation
13.5 Yakult Honsha Co., Ltd.
13.6 Microbiome Therapeutics, LLC
13.7 OSEL, Inc.
13.8 Second Genome, Inc.
13.9 Vithera Pharmaceuticals
13.10 Vedanta Biosciences, Inc.
  • Details on View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.
14 Appendix
14.1 Insights from Industry Experts
14.2 Discussion Guide
14.3 Other Developments
14.4 Knowledge Store
14.5 Introducing RT: Real-Time Market Intelligence
14.6 Available Customizations
14.7 Related Reports
14.8 Author Details

List of Tables:
Table 1 Human Microbiome Market Size, By Product, 2022-2025 (USD Million)
Table 2 Human Microbiome Market Size for Probiotics, By Region, 2022-2025 (USD Million)
Table 3 Human Microbiome Market for Foods, By Region, 2022-2025 (USD Million)
Table 4 Human Microbiome Market Size for Prebiotics, By Region, 2022-2025 (USD Million)
Table 5 Human Microbiome Market Size for Medical Foods, By Region, 2022-2025 (USD Million)
Table 6 Human Microbiome Market Size for Diagnostic Devices, By Region, 2020-2025 (USD Million)
Table 7 Human Microbiome Market Size for Drugs, By Region, 2022-2025 (USD Million)
Table 8 Human Microbiome Market Size for Other Probiotic Supplements, By Region, 2022-2025 (USD Million)
Table 9 Human Microbiome Market Size, By Application, 2022-2025 (USD Million)
Table 10 Human Microbiome Market Size for Therapeutic Applications, By Region, 2022-2025 (USD Million)
Table 11 Human Microbiome Market Size for Diagnostic Applications, By Region, 2021-2025 (USD Million)
Table 12 Human Microbiome Market Size, By Disease, 2022-2025 (USD Million)
Table 13 Human Microbiome Market Size for Acute Diarrhea, By Region, 2022-2025 (USD Million)
Table 14 Human Microbiome Market Size for Obesity, By Region, 2021-2025 (USD Million)
Table 15 Human Microbiome Market Size for Diabetes, By Region, 2022-2025 (USD Million)
Table 16 Human Microbiome Market Size for Autoimmune Disorders, By Region, 2021-2025 (USD Million)
Table 17 Human Microbiome Market Size for Cancer, By Region, 2022-2025 (USD Million)
Table 18 Human Microbiome Market Size for Mental Disorders, By Region, 2022-2025 (USD Million)
Table 19 Human Microbiome Market Size for Other Diseases, By Region, 2021-2025 (USD Million)
Table 20 Human Microbiome Research Spending Market Size, By Product, 2014-2021 (USD Million)
Table 21 Human Microbiome Research Spending Market Size for Instruments, By Type, 2014-2021 (USD Million)
Table 22 Human Microbiome Research Spending Market Size for Instruments, By Region, 2014-2021 (USD Million)
Table 23 North America: Human Microbiome Research Spending Market Size for Instruments, By Country, 2014-2021 (USD Million)
Table 24 Human Microbiome Research Spending Market Size for Laboratory Instruments, By Region, 2014-2021 (USD Million)
Table 25 North America: Human Microbiome Research Spending Market Size for Laboratory Instruments, By Country, 2014-2021 (USD Million)
Table 26 Human Microbiome Research Spending Market Size for Analyzers, By Region, 2014-2021 (USD Million)
Table 27 North America: Human Microbiome Research Spending Market Size for Analyzers, By Country, 2014-2021 (USD Million)
Table 28 Human Microbiome Research Spending Market Size for Consumables, By Type, 2014-2021 (USD Million)
Table 29 Human Microbiome Research Spending Market Size for Consumables, By Region, 2014-2021 (USD Million)
Table 30 North America: Human Microbiome Research Spending Market Size for Consumables, By Country, 2014-2021 (USD Million)
Table 31 Human Microbiome Research Spending Market Size for Kits, By Region, 2014-2021 (USD Million)
Table 32 North America: Human Microbiome Research Spending Market Size for Kits, By Country, 2014-2021 (USD Million)
Table 33 Human Microbiome Research Spending Market Size for Reagents, By Region, 2014-2021 (USD Million)
Table 34 North America: Human Microbiome Research Spending Market Size for Reagents, By Country, 2014-2021 (USD Million)
Table 35 Human Microbiome Research Spending Market Size, By Technology, 2014-2021 (USD Million)
Table 36 Human Microbiome Research Spending Market Size for Cell Culture Technology, By Region, 2014-2021 (USD Million)
Table 37 North America: Human Microbiome Research Spending Market Size for Cell Culture Technology, By Country, 2014-2021 (USD Million)
Table 38 Human Microbiome Research Spending Market Size for High-Throughput Technology, By Region, 2014-2021 (USD Million)
Table 39 North America: Human Microbiome Research Spending Market Size for High-Throughput Technology, By Country, 2014-2021 (USD Million)
Table 40 Human Microbiome Research Spending Market Size for Omics Technology, By Region, 2014-2021 (USD Million)
Table 41 North America: Human Microbiome Research Spending Market Size for Omics Technology, By Country, 2014-2021 (USD Million)
Table 42 Human Microbiome Research Spending Market Size for Computational Tools, By Region, 2014-2021 (USD Million)
Table 43 North America: Human Microbiome Research Spending Market Size for Computational Tools, By Country, 2014-2021 (USD Million)
Table 44 Human Microbiome Market Size, By Region, 2022-2025 (USD Million)
Table 45 Human Microbiome Research Spending Market Size, By Region, 2014-2021 (USD Million)
Table 46 North America: Human Microbiome Market Size, By Product, 2022-2025 (USD Million)
Table 47 North America: Human Microbiome Market Size, By Application, 2022-2025 (USD Million)
Table 48 North America: Human Microbiome Market Size, By Disease, 2022-2025 (USD Million)
Table 49 North America: Human Microbiome Research Spending Market Size, By Product, 2014-2021 (USD Million)
Table 50 North America: Human Microbiome Research Spending Market Size for Instruments, By Type, 2014-2021 (USD Million)
Table 51 North America: Human Microbiome Research Spending Market Size for Consumables, By Type, 2014-2021 (USD Million)
Table 52 North America: Human Microbiome Research Spending Market Size, By Technology, 2014-2021 (USD Million)
Table 53 U.S.: Human Microbiome Market Size, By Product, 2022-2025 (USD Million)
Table 54 U.S.: Human Microbiome Market Size, By Application, 2022-2025 (USD Million)
Table 55 U.S.: Human Microbiome Market Size, By Disease, 2022-2025 (USD Million)
Table 56 U.S.: Human Microbiome Research Spending Market Size, By Product, 2014-2021 (USD Million)
Table 57 U.S.: Human Microbiome Research Spending Market Size for Instruments, By Type, 2014-2021 (USD Million)
Table 58 U.S.: Human Microbiome Research Spending Market Size for Consumables, By Type, 2014-2021 (USD Million)
Table 59 U.S.: Human Microbiome Research Spending Market Size, By Technology, 2014-2021 (USD Million)
Table 60 Canada: Human Microbiome Market Size, By Product, 2022-2025 (USD Million)
Table 61 Canada : Human Microbiome Market Size, By Application, 2022-2025 (USD Million)
Table 62 Canada : Human Microbiome Market Size, By Disease, 2022-2025 (USD Million)
Table 63 Canada: Human Microbiome Research Spending Market Size, By Product, 2014-2021 (USD Million)
Table 64 Canada: Human Microbiome Research Spending Market Size for Instruments, By Type, 2014-2021 (USD Million)
Table 65 Canada: Human Microbiome Research Spending Market Size for Consumables, By Type, 2014-2021 (USD Million)
Table 66 Canada: Human Microbiome Research Spending Market Size, By Technology, 2014-2021 (USD Million)
Table 67 Europe: Human Microbiome Market Size, By Product, 2022-2025 (USD Million)
Table 68 Europe: Human Microbiome Market Size, By Application, 2022-2025 (USD Million)
Table 69 Europe: Human Microbiome Market Size, By Disease, 2022-2025 (USD Million)
Table 70 Europe: Human Microbiome Research Spending Market Size, By Product, 2014-2021 (USD Million)
Table 71 Europe: Human Microbiome Research Spending Market Size for Instruments, By Type, 2014-2021 (USD Million)
Table 72 Europe: Human Microbiome Research Spending Market Size for Consumables, By Type, 2014-2021 (USD Million)
Table 73 Europe: Human Microbiome Research Spending Market Size, By Technology, 2014-2021 (USD Million)
Table 74 Asia-Pacific: Human Microbiome Market Size, By Product, 2022-2025 (USD Million)
Table 75 Asia-Pacific: Human Microbiome Market Size, By Application, 2020-2025 (USD Million)
Table 76 Asia-Pacific: Human Microbiome Market Size, By Disease, 2022-2025 (USD Million)
Table 77 Apac: Human Microbiome Research Spending Market Size, By Product, 2014-2021 (USD Million
Table 78 Apac: Human Microbiome Research Spending Market Size for Instruments, By Type, 2014-2021 (USD Million)
Table 79 Apac: Human Microbiome Research Spending Market Size for Consumables, By Type, 2014-2021 (USD Million)
Table 80 Apac: Human Microbiome Research Spending Market Size, By Technology, 2014-2021 (USD Million)
Table 81 Row: Human Microbiome Market Size, By Product, 2022-2025 (USD Million)
Table 82 Row: Human Microbiome Market Size, By Application, 2022-2025 (USD Million)
Table 83 Row: Human Microbiome Market Size, By Disease, 2022-2025 (USD Million)
Table 84 Row: Human Microbiome Research Spending Market Size, By Product, 2014-2021 (USD Million)
Table 85 Row: Human Microbiome Research Spending Market Size for Instruments, By Type, 2014-2021 (USD Million)
Table 86 Row: Human Microbiome Research Spending Market Size for Consumables, By Type, 2014-2021 (USD Million)
Table 87 Row: Human Microbiome Research Spending Market Size, By Technology, 2014-2021 (USD Million)
Table 88 Agreements, Partnerships, and Collaborations, 2013-2016
Table 89 Expansions, 2013-2016
Table 90 Product Launches and Approvals, 2013-2016
Table 91 Other Developments, 2013-2016

List of Figures:
Figure 1 Human Microbiome: Market Segmentation
Figure 2 Human Microbiome Research Spending: Market Segmentation
Figure 3 Research Design
Figure 4 Market Size Estimation: Bottom-Up Approach
Figure 5 Market Size Estimation: Top-Down Approach
Figure 6 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 7 Probiotics Segment To Dominate the Human Microbiome Market During the Forecast Period
Figure 8 Consumables Segment To Witness the Highest Growth Rate in the Microbiome Research Spending Market from 2016 To 2021
Figure 9 Cell Culture Technologies To Dominate the Human Microbiome Research Spending Market in 2015
Figure 10 Geographical Snapshot of the Global Human Microbiome Market, 2022
Figure 11 Growing Prevalence of Lifestyle Diseases and Increasing Acceptance of Microbiome-Based Products Are Major Growth Drivers
Figure 12 Probiotics Segment Dominated the Human Microbiome Market in 2022
Figure 13 North America Accounted for the Largest Share of the Human Microbiome Market in 2022-2025
Figure 14 North America To Grow at the Highest CAGR During the Forecast Period
Figure 15 Developed Regions To Grow at Higher CAGRs from 2022 To 2025
Figure 16 Cell Culture Technology Segment Dominated the Human Microbiome Research Spending Market in 2015
Figure 17 Human Microbiome Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Funds Provided for Microbiome Research By Various Medical Research Agencies
Figure 19 Probiotics Segment To Command the Largest Share of the Human Microbiome Product Market By 2025
Figure 20 the Therapeutics Segment To Command the Largest Share of the Human Microbiome Applications Market By 2025
Figure 21 Acute Diarrhea Expected To Be the Largest Disease Segment of the Human Microbiome Market in 2022
Figure 22 Geographic Snapshot (2022): North America Will Be the Fastest-Growing Region By 2022
Figure 23 North America To Grow at the Fastest Rate in the Human Microbiome Product Market from 2022 To 2025
Figure 24 Europe: Human Microbiome Market Snapshot
Figure 25 Companies Adopted Agreements, Collaborations, and Partnerships as the Key Growth Strategy Over the Last Three Years
Figure 26 Battle for Market Share: Agreements, Collaborations, and Partnerships Are Key Growth Strategies for Market Players
Figure 27 Geographic Revenue Mix of Top 3 Market Players
Figure 28 E.I. du Pont de Nemours and Company: Company Snapshot (2015)
Figure 29 Merck & Co., Inc.: Company Snapshot (2015)
Figure 30 Yakult Honsha Co., Ltd.: Company Snapshot (2016)
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • E.I. du Pont de Nemours and Company
  • Enterome Bioscience
  • Merck & Co., Inc.
  • Metabiomics Corporation
  • Microbiome Therapeutics, LLC
  • OSEL, Inc.
  • Second Genome, Inc.
  • Vedanta Biosciences, Inc.
  • Vithera Pharmaceuticals
  • Yakult Honsha Co., Ltd.
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll